Products for Research Use Only
RegisterLogin

Fontolizumab

CAT: 0804-HY-P99292-01Size: 1 mgDry Ice: YesHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99292-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Fontolizumab (HuZAF) is a humanized monoclonal anti-IFN-gamma antibody. Fontolizumab is an immunosuppressive agent. Fontolizumab can be used in research of Crohn’s disease[1].
CAS Number
326859-36-3
Product Name Alternative
HuZAF; Anti-Human IFNG Recombinant Antibody
UNSPSC
12352203
Target
IFNAR
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/fontolizumab.html
Purity
97.18
Solubility
10 mM in DMSO
Smiles
[Fontolizumab]
Molecular Weight
(144.8 kDa)
References & Citations
[1]Hommes DW, et, al. Fontolizumab, a humanised anti-interferon gamma antibody, demonstrates safety and clinical activity in patients with moderate to severe Crohn's disease. Gut. 2006 Aug;55 (8) :1131-7.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2

Alternative Products

CatalogName
T76808-01Fontolizumab
591870Fontolizumab (IFNG)
GTR18337974-01Fontolizumab Antibody
HF813026-01Research Grade Fontolizumab
C00622-1mg*5Fontolizumab (Anti-IFNg)
047818IFNg (fontolizumab) discontinued
E55B0269Fontolizumab (Reference antibody)
ICH5554-1mgFontolizumab Biosimilar - Research Grade
GTR18781379-01(Fontolizumab) Biosimilar Reference Antibody
GTR18697996-01Fontolizumab Human Monoclonal Antibody

Popular Products